UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): May 30, 2013

CATALYST PHARMACEUTICAL PARTNERS, INC.

(Exact Name Of Registrant As Specified In Its Charter)

 

Delaware		001-33057		76-0837053
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 

355 Alhambra Circle Suite 1500 Coral Gables, Florida		33134
(Address of principal executive offices)		(Zip Code)

 

Registrant’s telephone number, including area code:		(305) 529-2522

        Not Applicable        

Former Name or Former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.07 Submission of Matters to a Vote of Security Holders

On May 30, 2013, Catalyst Pharmaceutical Partners, Inc. (the “Company”) held its Annual Meeting of Stockholders at the Hyatt Regency Coral Gables, 50 Alhambra Plaza, Coral Gables, Florida. The final voting results on the matters considered at the meeting are as follows:

 

1.	Election of Directors:

 

Name		Votes For		Votes Withheld		Broker Non-Votes
Patrick J. McEnany		17,855,170		263,730		15,151,838
Philip H. Coelho		17,822,170		296,730		15,151,838
Hubert E. Huckel		17,800,055		318,845		15,151,838
Charles B. O’Keeffe		17,852,216		266,684		15,151,838
David S. Tierney		17,855,770		263,130		15,151,838

 

2.	Approval, on an advisory basis, of the compensation of the Company’s named executive officers:

 

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
17,604,563		420,034		94,303		15,151,838

 

3.	Selection, on an advisory basis, of the frequency of “say-on-pay” votes:

 

One Year		Two Years		Three Years		Abstain		Broker Non-Votes
11,366,380		281,389		6,178,514		292,617		15,151,838

 

4.	Ratification of the selection of Grant Thornton, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013:

 

Votes For		Votes Against		Votes Abstained
33,043,182		153,011		74,545

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Dated: June 3, 2013